Dean Investment Associates’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-21,922
Closed -$1.81M 222
2024
Q2
$1.81M Buy
21,922
+94
+0.4% +$8.27K 0.26% 159
2024
Q1
$1.86M Buy
21,828
+10,885
+99% +$854K 0.26% 161
2023
Q4
$936K Sell
10,943
-448
-4% -$38.7K 0.13% 178
2023
Q3
$1.02M Sell
11,391
-1,511
-12% -$135K 0.17% 177
2023
Q2
$1.1M Buy
12,902
+5,304
+70% +$448K 0.18% 186
2023
Q1
$629K Sell
7,598
-378
-5% -$30.6K 0.1% 191
2022
Q4
$627K Buy
7,976
+338
+4% +$27.2K 0.11% 199
2022
Q3
$565K Buy
7,638
+129
+2% +$9.26K 0.12% 200
2022
Q2
$489K Sell
7,509
-5,005
-40% -$296K 0.1% 214
2022
Q1
$791K Sell
12,514
-10,134
-45% -$551K 0.14% 199
2021
Q4
$1.2M Buy
22,648
+3,627
+19% +$221K 0.21% 180
2021
Q3
$1.34M Sell
19,021
-1,876
-9% -$118K 0.25% 165
2021
Q2
$1.39M Buy
+20,897
New +$1.48M 0.26% 176
2014
Q4
Sell
-41,525
Closed -$1.45M 233
2014
Q3
$1.45M Hold
41,525
0.35% 91
2014
Q2
$1.47M Buy
+41,525
New +$1.39M 0.34% 97

Other funds holding HAE

Dean Investment Associates's HAE Position: Q3 2024 in Review

Dean Investment Associates sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 21,922 shares — an estimated $1.81M sold.

Dean Investment Associates first reported a position in HAE in Q2 2014 and held it in 15 quarters. The position peaked at $1.86M in Q1 2024. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Dean Investment Associates reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Dean Investment Associates sold 21,922 Haemonetics shares in Q3 2024, an estimated $1.81M.
  • Dean Investment Associates first reported a position in Haemonetics in Q2 2014 and held it in 15 quarters.
  • Dean Investment Associates's Haemonetics position peaked at $1.86M in Q1 2024.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Dean Investment Associates's 13F filing for Q3 2024, filed 15 Nov 2024.